$27.92
arrow_drop_down0.17%Key Stats | |
---|---|
Open | $27.87 |
Prev. Close | $27.95 |
EPS | -2.72 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 27.87 | 27.87 |
52 Week Range | 26.69 | 73.80 |
Ratios | |
---|---|
EPS | -2.72 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Geographic Atrophy (GA) Market Size to Hit USD 50.0 Billion by 2032 with a 8.6% CAGR – SNS Insider
Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
What Analysts Are Saying About Apellis Pharmaceuticals Stock
Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU
Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?